الابحاث

South Egypt Cancer Institute

Assiut University

Department of Medical Oncology
# Title Research Member Research Year
81 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Dr. Ayat allah Ali yousseif 2021
82 Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study Dr. Mayada Fawzy Sedik Farghaly 2021
83 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Dr. Salah Mabrouk Khallaf Abd Rabou 2021
84 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

 		Prof. Ashraf Zeidan Abdalla Ahmed 2020
85 Right and Left Colon Cancer: Clinico-Pathological Features and Treatment Results (South Egypt
Cancer Institute Experience) 		Matta Gerges Mounir Meshreky 2020
86 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

 		Rabab Mohammed Mamdouh Abdelhameed 2020
87 Evaluation the Possibility of Using of miRNA-21 as a Prognostic and Predictive Factor in Colorectal Cancer (South Egypt Experience)
 		Sanaa Saber Abdelraheem Barakat 2020
88 Is survival with Conservative Breast Therapy becoming Superior to that with Modified Radical Mastectomy alone for the Treatment of Early Breast Cancer in this Era? Dr. Mayada Fawzy Sedik Farghaly 2020
89 Predictive and Prognostic Factors for the Outcome of the Patients Receiving Pegylated Liposomal Doxorubicin for Advanced Breast Cancer Dr. Salah Mabrouk Khallaf Abd Rabou 2020
90 2. The reliability of the computed
tomography perfusion parameters as a
predictor of colorectal cancer grade:
influence of tumor region of interest
position
 		Dr. Hanaan Ahmed Mohammed Ahmed 2020